Table 3

Ang1, Ang2, Agn4, Tie1, and Tie2 expression levels (means of ΔCt±standard deviation) according to the demographic and clinical data of the patients.

Characteristics	N	Ang1	P	Ang2	P	Ang4	P	Tie1	P	Tie2	P
Age			0.790		0.540		0.759		0.425		0.257
First decade	23	6.8±1.5		5.1±1.1		9.2±3.3		6.3±1.1		4.4±1.1
Second decade	17	6.9±1.4		4.9±1.2		9.0±3.2		6.2±1.1		4.1±1.2
Sex			0.830		0.236		0.556		0.317		0.688
Male	22	7.2±1.3		4.8±1.2		9.3±3.5		6.5±1.3		4.1±1.2
Female	18	7.3±1.2		5.0±1.1		9.5±3.6		6.3±1.3		4.2±1.3
BM blasts			0.431		0.756		0.457		0.345		0.264
25–55%	4	7.3±1.5		5.5±1.2		9.0±3.5		6.6±1.4		4.5±1.3
56–75%	7	7.2±1.3		5.3±1.2		8.8±3.6		6.3±1.5		4.3±1.5
76–100%	29	7.2±1.1		5.4±1.1		8.7±3.2		6.4±1.2		4.4±1.2
PB WBCs			0.322		0.587		0.632		0.435		0.475
<50	15	7.4±1.3		5.4±1.2		9.0±3.3		6.1±1.2		4.2±1.3
>50	25	7.1±1.2		5.3±1.4		8.9±3.5		6.2±1.6		4.4±1.4
WHO classification			0.719		0.365		0.235		0.353		0.476
Early pre-B-ALL	16	6.7±1.3		5.2±1.3		8.6±3.4		6.2±1.3		4.2±1.4
Early Pre-B-ALL	24	6.9±1.4		5.3±1.4		8.5±3.2		6.4±1.4		4.4±1.5

Abbreviations: ALL, acute lymphoblastic leukemia; BM, bone marrow; WBC, white blood cell; WHO, World Health Organization.